Diagnostic studies Clause Samples

Diagnostic studies. Reports on interviews with ▇▇▇▇▇▇ Youth/NMD;
Diagnostic studies. PLEASE LIST THE APPROXIMATE DATE OF TEST, THE NAME OF THE FACILITY WHERE THE TEST WAS PERFORMED, THE NAME OF THE ORDERING PHYSICIAN AND THE RESULTS, IF KNOWN. TEST DATE FACILITY PHYSICIAN RESULTS EMG ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Patient Name : Account #: MR # : Date : Headaches Trouble with hearing Trouble with eyesight Nasal discharge Hay Fever, frequent sneezing Sinus trouble, post nasal drip Hoarseness Ulcer of tongue or mouth Trouble with gums or teeth Sore throat Asthma, wheezing Cough Cough up blood Tuberculosis Shortness of breath High blood pressure Chest pain Irregular beat or palpitation of heart Increased thirst, hunger Sudden weight change Sensitive to heat/cold Change in skin, body hair Change in sex drive Rash Tumor on skin Frequency urgency or pain with urination Passed blood or kidney stone Trouble starting or stopping of urinary stream Trouble swallowing Abdominal pain, nausea, vomiting Acid Reflux (“Heartburn”) Stomach ulcer/Duodenal ulcer Black bowel movements Diarrhea Constipation Hemorrhoids or rectal itching Low back pain Joint pain Arthritis Neck pain Backache Balance prolems Numbness or tingling anywhere Weakness Trouble walking Problems with sleep Dizziness Depression Fatigue Anemia or difficulty with bleeding Sexual problems Awaken at night with shortness of breath Please check any of the following below that you have had or currently have a problem with: Alcohol Acquired Brain Injury ALS Asthma Bladder Pain / Spasms Blood Clots Blood in Stool Blood in Urine Cerebral Palsy Cigarettes Current Pregnancy Diabetes Drugs Dysreflexia Frequent UTI Gynecological Problems Hay Fever / Allergies High Blood Pressure HIV (or AIDS) Impaction Kidney Failure Multiple Sclerosis Neurogenic Bladder Neurogenic Bowel Paraplegia Pneumonia Post Polio Psychiatric Problems Respiratory Failure Quadriplegia / Tetraplegia Seizures Skin Problem ▇▇▇▇▇ Bifida Spinal Problems Stroke Ventilator Use ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Date Patient Name Medical Record Number
Diagnostic studies. Report of interviews with YOUNfi ADULT.
Diagnostic studies. Reports on interviews with ▇▇▇▇▇▇ child;
Diagnostic studies. 1. Carrying out of a comprehensive diagnostic study aimed at assessing all the current arrangements covering the financial, operational, technical, legal and contractual aspects pertaining to the exploitation of oil resources and the management of oil revenues with a view to designing a comprehensive reform program aimed at improving the management of the Borrower’s petroleum sector. 2. Carrying out of a procurement assessment review with a view to improving the legal and regulatory framework for procurement operations. Part E: Economic Policy Formulation and Capacity Building 1. Strengthening the Borrower’s capacity to formulate appropriate economic policies and to coordinate and monitor their implementation specifically in the areas of: (a) civil service reform; (b) fiscal federalism; and (c) trade policy reform; all through the provision of technical advisory services and the carrying out of seminars/workshops, and study tours. 2. Carrying out a training program for relevant staff of the Borrower involved in the carrying out of any part of the Project in subject matters related to the implementation of the said parts of the Project. (a) Establishment of a distance learning center, to increase the access of the Borrower’s and private sector managers to global innovations and information. (b) Installation in DLC of (i) a video-conference room with about a fifty
Diagnostic studies. Reports on interviews with Youth/NMD; 3 4 5 professionals; medical/dental visits and

Related to Diagnostic studies

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus, or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMA, Health Canada and other comparable regulatory agencies outside of the U.S. to which they are subject, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312, and 812; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;